Interaction of an S100A9 gene variant with saturated fat and carbohydrates to modulate insulin resistance in 3 populations of different ancestries.

BACKGROUND S100 calcium-binding protein A9 (S100A9) has previously been identified as a type 2 diabetes (T2D) gene. However, this finding requires independent validation and more in-depth analyses in other populations and ancestries. OBJECTIVES We aimed to replicate the associations between an S100A9 variant and insulin resistance and T2D and to initiate an investigation of potential interactions with the habitual diet in several independent populations. DESIGN We investigated the association of the S100A9 variant rs3014866 with insulin resistance and T2D risk and its interactions with diet in 3 diverse populations as follows: the CORDIOPREV (Coronary Diet Intervention with Olive Oil and Cardiovascular Prevention; n = 711), which consisted of Spanish white adults; the GOLDN (Genetics of Lipids Lowering Drugs and Diet Network; n = 818), which involved North American non-Hispanic white adults; and Hispanic adults who participated in the BPRHS (Boston Puerto Rican Health Study; n = 1155). RESULTS Meta-analysis indicated that T carriers presented a lower risk of T2D than CC carriers (pooled OR: 0.714; 95% CI: 0.584, 0.845; P = 0.002). In all 3 populations (CORDIOPREV, GOLDN, and BPRHS), we showed a significant interaction between the rs3014866 single nucleotide polymorphism and dietary SFA:carbohydrate ratio intake for the homeostasis model assessment of insulin resistance (HOMA-IR) (P = 0.028, P = 0.017, and P = 0.026, respectively). CC carriers had a significantly higher HOMA-IR only when SFA:carbohydrate intake was high (P = 0.045 for the CORDIOPREV, P = 0.033 for the GOLDN, and P = 0.046 for the BPRHS) but not when SFA:carbohydrate ratio intake was low. CONCLUSIONS The minor allele (T) of the S100A9 variant rs3014866 is associated with lower T2D risk in 3 populations of different ancestries. Note that individuals with the high-risk CC genotype may be more likely to benefit from a low SFA:carbohydrate ratio intake to improve insulin resistance as evaluated with the use of the HOMA-IR. These trials were registered at clinicaltrials.gov as NCT00924937 (CORDIOPREV), NCT00083369 (GOLDN), and NCT01231958 (BPRHS).

[1]  I-Min Lee,et al.  Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. , 2015, JAMA internal medicine.

[2]  P. Reaven,et al.  Dietary models of insulin resistance. , 2015, Metabolism: clinical and experimental.

[3]  Ben Ommen,et al.  The insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: the CORDIOPREV-DIAB randomised clinical trial , 2015, Diabetologia.

[4]  J. Ordovás,et al.  Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis , 2014, European journal of clinical investigation.

[5]  Yu-Chi Lee,et al.  CardioGxE, a catalog of gene-environment interactions for cardiometabolic traits , 2014, BioData Mining.

[6]  L. Marullo,et al.  Insights into the Genetic Susceptibility to Type 2 Diabetes from Genome-Wide Association Studies of Glycaemic Traits , 2014, Current Diabetes Reports.

[7]  D. Mozaffarian.  Saturated fatty acids and type 2 diabetes: more evidence to re-invent dietary guidelines. , 2014, The lancet. Diabetes & endocrinology.

[8]  J. Ordovás,et al.  Beneficial effect of CLOCK gene polymorphism rs1801260 in combination with low-fat diet on insulin metabolism in the patients with metabolic syndrome , 2014, Chronobiology international.

[9]  J. Shaw,et al.  Global estimates of diabetes prevalence for 2013 and projections for 2035. , 2014, Diabetes Research and Clinical Practice.

[10]  B. Hedblad,et al.  Plasma S100A8/A9 Correlates With Blood Neutrophil Counts, Traditional Risk Factors, and Cardiovascular Disease in Middle-Aged Healthy Individuals , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[11]  C. Geczy,et al.  Calgranulins may contribute vascular protection in atherogenesis. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[12]  F. Wolf,et al.  Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers , 2016, Clinical Diabetes.

[13]  G. Rossi.  Diagnosis and Classification of Diabetes Mellitus , 2012, Diabetes Care.

[14]  Yu Xu,et al.  Advanced research on risk factors of type 2 diabetes , 2012, Diabetes/metabolism research and reviews.

[15]  J. Moreno-Navarrete,et al.  Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes. , 2012, European journal of endocrinology.

[16]  Simon C. Potter,et al.  Mapping cis- and trans-regulatory effects across multiple tissues in twins , 2012, Nature Genetics.

[17]  Tanya M. Teslovich,et al.  Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways , 2012, Nature Genetics.

[18]  Donna K Arnett,et al.  A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network , 2012, Pharmacogenetics and genomics.

[19]  J. Moreno-Navarrete,et al.  Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes , 2012, Journal of Molecular Medicine.

[20]  M. Martínez-González,et al.  The role of diet in the prevention of type 2 diabetes. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[21]  M. Raftery,et al.  Oxidative modifications of DAMPs suppress inflammation: the case for S100A8 and S100A9. , 2011, Antioxidants & redox signaling.

[22]  David R Bassett,et al.  2011 Compendium of Physical Activities: a second update of codes and MET values. , 2011, Medicine and science in sports and exercise.

[23]  Thomas M. Aune,et al.  Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes. , 2011, Genes and immunity.

[24]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[25]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[26]  J. Fernández-Real,et al.  Increased Levels of Calprotectin in Obesity Are Related to Macrophage Content: Impact on Inflammation and Effect of Weight Loss , 2011, Molecular medicine.

[27]  M. Smolensky,et al.  ETHICS AND METHODS FOR BIOLOGICAL RHYTHM RESEARCH ON ANIMALS AND HUMAN BEINGS , 2010, Chronobiology international.

[28]  Sabrina E. Noel,et al.  The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities , 2010, BMC public health.

[29]  Dolores Corella,et al.  Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain , 2010, British Journal of Nutrition.

[30]  D. Arnett,et al.  Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study. , 2009, Atherosclerosis.

[31]  U. Risérus.  Fatty acids and insulin sensitivity , 2008, Current opinion in clinical nutrition and metabolic care.

[32]  E. Burchard,et al.  Population admixture associated with disease prevalence in the Boston Puerto Rican health study , 2008, Human Genetics.

[33]  I. Borecki,et al.  The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. , 2007, Clinical chemistry.

[34]  K. Petersen,et al.  Disordered lipid metabolism and the pathogenesis of insulin resistance. , 2007, Physiological reviews.

[35]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[36]  D. Arnett,et al.  Effect of influenza vaccine on markers of inflammation and lipid profile. , 2005, The Journal of laboratory and clinical medicine.

[37]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[38]  M. Uusitupa,et al.  Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus , 2005 .

[39]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[40]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[41]  L. Pérusse,et al.  The PPAR‐gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study , 2003, Clinical genetics.

[42]  J. Jobe,et al.  Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study. , 2002, Journal of the American Dietetic Association.

[43]  D. Midthune,et al.  Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study. , 2001, American journal of epidemiology.

[44]  J. López-Miranda,et al.  A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons , 2001, Diabetologia.

[45]  S. O’Rahilly,et al.  Arachidonic Acid Stimulates Glucose Uptake in 3T3-L1 Adipocytes by Increasing GLUT1 and GLUT4 Levels at the Plasma Membrane , 2001, The Journal of Biological Chemistry.

[46]  G. Reach,et al.  PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. , 2001, Diabetes.

[47]  M. Comporti,et al.  Protection of erythrocytes against oxidative damage and autologous immunoglobulin G (IgG) binding by iron chelator fluor-benzoil-pyridoxal hydrazone. , 2000, Biochemical pharmacology.

[48]  T. Willson,et al.  The PPARs: from orphan receptors to drug discovery. , 2000, Journal of medicinal chemistry.

[49]  M. Leppert,et al.  A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. , 1999, Diabetes.

[50]  Johan Auwerx,et al.  A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.

[51]  R. Paffenbarger,et al.  Physical activity and stroke incidence: the Harvard Alumni Health Study. , 1998, Stroke.

[52]  K. Tucker,et al.  Adaptation of a food frequency questionnaire to assess diets of Puerto Rican and non-Hispanic adults. , 1998, American journal of epidemiology.